Home > Cashflow Statement > BETA DRUGS

BETA DRUGS
Cash Flow from Financing Activities

    Back to Cashflow Statement
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹118 Cr₹-7.49 Cr₹-2.47 Cr₹-0.97 Cr₹-7.71 Cr

What is the latest Cash Flow from Financing Activities ratio of BETA DRUGS ?

The latest Cash Flow from Financing Activities ratio of BETA DRUGS is ₹118 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹118 Cr
Mar2024₹-7.49 Cr
Mar2023₹-2.47 Cr
Mar2022₹-0.97 Cr
Mar2021₹-7.71 Cr

How is Cash Flow from Financing Activities of BETA DRUGS Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹118 Cr
Positive
Mar2024 ₹-7.49 Cr
Negative
Mar2023 ₹-2.47 Cr
Negative
Mar2022 ₹-0.97 Cr
Negative
Mar2021 ₹-7.71 Cr -

Compare Cash Flow from Financing Activities of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,634.8 Cr 0.9% 8.4% 45% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -0.1% 0.5% 14% Stock Analytics
DIVIS LABORATORIES ₹218,972.0 Cr -0.9% 21.1% 25.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,358.0 Cr -1.3% 1.1% 32.7% Stock Analytics
CIPLA ₹118,916.0 Cr 0.2% 2.1% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,824.0 Cr 0.2% -7.7% -7.5% Stock Analytics


BETA DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

0.9%

8.4%

45%

SENSEX

0.5%

2.6%

-3.7%


You may also like the below Video Courses